spacer
home > ict > summer 2019 > the service model dichotomy
PUBLICATIONS
International Clinical Trials

The Service Model Dichotomy





In the context of progressive and steady economic growth, sponsors and CROs are continually looking for the right outsourcing models to sustain their portfolios and share complementary expertise for the long term, while ensuring flexibility in the short term. Broadly speaking, outsourcing models adhere to one of the following three approaches:

  • A full-service approach using either an exclusive or dual-vendor strategy
  • Functional approaches using different strategic vendors for different service areas
  • A more ad hoc, preferred vendor approach where competitive bidding continues

While each approach has its pros and cons, the market is quickly shifting to one of dichotomy, where either functional service provision (FSP) or full-service models are the preferred option among trial sponsors.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Daniel Chapple is a Director at Quanticate and oversees a number of functions, including commercial activities. Daniel has over 20 years of experience within the drug development field, with over 15 years spent in the CRO and business process outsourcing sector. He holds a doctorate in Biochemistry, Microbiology, and Immunology from the University of London, UK, is a Fellow of the Institute of Sales Management (FISM), and is a certified ‘green belt’ in Lean Six Sigma.


Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020.
More info >>

White Papers

RSSL introduces same-day mycoplasma testing service in UK

RSSL

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement